211 related articles for article (PubMed ID: 15175915)
1. Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone.
Yeung CK; Chan KP; Chan CK; Pang CP; Lam DS
Jpn J Ophthalmol; 2004; 48(3):236-42. PubMed ID: 15175915
[TBL] [Abstract][Full Text] [Related]
2. Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells.
Szurman P; Kaczmarek R; Spitzer MS; Jaissle GB; Decker P; Grisanti S; Henke-Fahle S; Aisenbrey S; Bartz-Schmidt KU
Exp Eye Res; 2006 Sep; 83(3):584-92. PubMed ID: 16684520
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells.
Narayanan R; Mungcal JK; Kenney MC; Seigel GM; Kuppermann BD
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):722-8. PubMed ID: 16431973
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells.
Chang YS; Wu CL; Tseng SH; Kuo PY; Tseng SY
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2792-8. PubMed ID: 17525214
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of preservative-free triamcinolone acetonide on cultured human retinal pigment epithelial cells.
Kaczmarek R; Szurman P; Misiuk-Hojło M; Grzybowski A
Med Sci Monit; 2009 Aug; 15(8):BR227-31. PubMed ID: 19644411
[TBL] [Abstract][Full Text] [Related]
6. Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo.
Szurman P; Sierra A; Kaczmarek R; Jaissle GB; Wallenfels-Thilo B; Grisanti S; Lüke M; Bartz-Schmidt KU; Spitzer MS
Exp Eye Res; 2007 Jul; 85(1):44-53. PubMed ID: 17475249
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis.
Valamanesh F; Torriglia A; Savoldelli M; Gandolphe C; Jeanny JC; BenEzra D; Behar-Cohen F
Mol Vis; 2007 Sep; 13():1746-57. PubMed ID: 17960113
[TBL] [Abstract][Full Text] [Related]
8. Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells.
Tong JP; Lam DS; Chan WM; Choy KW; Chan KP; Pang CP
Mol Vis; 2006 Dec; 12():1490-5. PubMed ID: 17167405
[TBL] [Abstract][Full Text] [Related]
9. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone.
Yeung CK; Chan KP; Chiang SW; Pang CP; Lam DS
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5293-300. PubMed ID: 14638729
[TBL] [Abstract][Full Text] [Related]
10. In vitro benzyl alcohol cytotoxicity: implications for intravitreal use of triamcinolone acetonide.
Chang YS; Wu CL; Tseng SH; Kuo PY; Tseng SY
Exp Eye Res; 2008 Jun; 86(6):942-50. PubMed ID: 18420195
[TBL] [Abstract][Full Text] [Related]
11. The effect of short-term exposure of triamcinolone acetonide on fibroblasts and retinal pigment epithelial cells.
Oh J; Jung YS; Kim GS; Oh IK; Rho BK; Huh K
Acta Ophthalmol Scand; 2007 Nov; 85(7):786-90. PubMed ID: 17617200
[TBL] [Abstract][Full Text] [Related]
12. Triamcinolone acetonide-mediated oxidative injury in retinal cell culture: comparison with dexamethasone.
Chung H; Hwang JJ; Koh JY; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5742-9. PubMed ID: 18055827
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone.
Fan BJ; Wang DY; Tham CC; Lam DS; Pang CP
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1886-97. PubMed ID: 18436822
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro toxicity of indocyanine green to that of trypan blue in human retinal pigment epithelium cell cultures.
Gale JS; Proulx AA; Gonder JR; Mao AJ; Hutnik CM
Am J Ophthalmol; 2004 Jul; 138(1):64-9. PubMed ID: 15234283
[TBL] [Abstract][Full Text] [Related]
15. Sodium hyaluronate gels as a drug-release system for corticosteroids: release kinetics and antiproliferative potential for glaucoma surgery.
Spitzer MS; Yoeruek E; Kaczmarek RT; Sierra A; Aisenbrey S; Grisanti S; Bartz-Schmidt KU; Szurman P
Acta Ophthalmol; 2008 Dec; 86(8):842-8. PubMed ID: 19086928
[TBL] [Abstract][Full Text] [Related]
16. The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil.
Spitzer MS; Kaczmarek RT; Yoeruek E; Petermeier K; Wong D; Heimann H; Jaissle GB; Bartz-Schmidt KU; Szurman P
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2337-43. PubMed ID: 19098319
[TBL] [Abstract][Full Text] [Related]
17. Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibility.
Spitzer MS; Mlynczak T; Schultheiss M; Rinker K; Yoeruek E; Petermeier K; Januschowski K; Szurman P
Retina; 2011 Nov; 31(10):2050-7. PubMed ID: 21747324
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
19. Cell viability effects of triamcinolone acetonide and preservative vehicle formulations.
Shaikh S; Ho S; Engelmann LA; Klemann SW
Br J Ophthalmol; 2006 Feb; 90(2):233-6. PubMed ID: 16424540
[TBL] [Abstract][Full Text] [Related]
20. In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment.
Kernt M; Neubauer AS; Ulbig MW; Kampik A; Welge-Lüssen U
J Cataract Refract Surg; 2008 Mar; 34(3):480-8. PubMed ID: 18299076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
